43rd Annual Meeting 
of the European Society for 

Blood and Marrow Transplantation
26-29 March 2017 • Marseille, France
SIGN UP FOR UPDATES
REGISTER NOW
  • Home

  • Meeting Information

  • Abstracts

  • Program

  • Registration & Accommodation

  • Media

  • Support & Exhibition

  • More

    Copyright © 2016 EBMT2017.org. All Rights Reserved
    Meeting Organizers
    CME Congresses
    P: +972 3 555 0188
    F: +972 3 540 1566
    ebmt@cme-congresses.com
    Venue 
    Palais des Congrès - Marseille Chanot 
    Parc Chanot, Rond-Point du Prado, 13009 Marseille, France 
    www.marseille-chanot.com
    Contact Information
    Abstracts
    ebmt.abstracts@cme-congresses.com

    Registration & Accommodation 
    ebmt.reg@cme-congresses.com
    Membership
    membership@ebmt.org

    Special Sessions

    ​

    Monday, March 27th

    11:00-12:00 - Morgiou

    S1: Social Media Session

    Chairs:                 Naveen Pemmaraju, USA - @doctorpemm; Navneet Majhail, USA - @BldCancerDoc &
                         
            Mélanie Chaboissier, Spain - @TheEBMT
    11:00-11:10         Everything you need to know about Twitter: Navneet Majhail, USA

    11:10-11:30         Social Media and the Adolescent and Young Adult cancer community: Naveen Pemmaraju, USA

    11:30-11:50         Social Media for connecting doctors: the Myeloproliferative neoplasms (MPNs) model #mpnsm:
                         
            Naveen Pemmaraju, USA

    11:50-12:00         Discussion with the audience and the panel of Twitter ambassadors

     

    Tuesday, March 28th

    09:00-10:30 - Endoume 1

    S2: How to get published?

    09:00-10:30         How to get published (in collaboration with NPG): Junia Melo, Australia

     

    11:00-12:30 - Podestat

    S3: Access to innovations: the pharma-academia partnership

    Chairs:                  Dominique Maraninchi, France; Catherine Bollard, USA & Mohamad Mohty, France
    11:00-11:15         Evaluations of novel drugs across Europe: Jean-Luc Harousseau, France

    11:15-11:30         Access to innovation and economic issues: Challenges for the French national authority for health (HAS):
                         
            Agnès Buzyn, France

    11:30-11:45         Innovation from bench to bedside: Claudio Bordignon, Italy

    11:45-12:00         The pharma perspective: Emmanuelle Quilès, France

    12:00-12:30         Debate with the audience: Chairs and speakers

    ​

    14:00-16:00

    Statistical Symposium - Podestat

    Chairs:                   Hein Putter, The Netherlands & Simona Iacobelli, Italy
    14:00-14:30          Methodology in relative survival: Maja Pohar Perme, Slovenia

    14:30-15:00          Relative Survival: An application on EBMT data: Ariane Boumendil, France

    15:00-15:30          Evaluating the benefit of HCT - propensity score versus genetic randomization: Sylvie Chevret, France

    15:30-16:00          Interval censoring: some problems and some solutions: Karen Leffondré, France

    ​

    14:30-15:30 - Hall 1

    S4: Continuous medical education for transplant physicians

    Chairs:                  Mohamad Mohty, France & André Tichelli, Switzerland
    14:30-14:50         JACIE requirements: Riccardo Saccardí, Italy

    14:50-15:10         Accreditation in medical education: the view from the EBAH: André Tichelli, Switzerland

    15:10-15:30         EBMT initiative: Nicolaus Kröger, Germany

    ​

    16:30-18:00 - Auditorium

    S5: Presidential Symposium

    Chairs:                  Mohamad Mohty, France & Christian Chabannon, France
    16:30-17:00         Honorary and Clinical Achievement awards

                                  Awardees:

                                  Dean Buckner, Honorary

                                  Alex R. Zander, Honorary

                                  Dominique Maraninchi, Clinical Achievement

                                  Ljiljana Tukic, Clinical Achievement
    17:00-17:10         The UM171 Cord Blood Expansion Trial: Smaller, Better HLA Matched Cords in Short 7 Day Fedbatch Cultures
                                  Already Provide Clinical and Cost Benefits: Sandra Cohen, Canada

    17:10-17:20         Letermovir (LET) for prevention of cytomegalovirus (CMV) infection: Results from a Phase III randomized, double-
                                  blind, placebo (PBO)-controlled trial in adult allogeneic hematopoietic cell transplant (alloHCT) recipients: 
                         
            Per Ljungman, Sweden

    17:20-17:30         Myeloablative autologous transplantation of CD343+_ selected hematopoietic stem cells vs. monthly intravenous
                         
            cyclophosphamide for severe scleroderma with internal organ involvement: Outcomes of the randomized
                         
            scleroderma: Cyclophosphamide or transplantation (SCOT) trial: Keith Sullivan, USA

    17:30-17:40         Application of the disease risk index for risk stratification of allogeneic hematopoietic stem cell transplantation in a
                         
            large cohort of the European Society for Blood and Marrow Transplantation (EBMT): Roni Shouval, Israel

    17:40-17:50         Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant
                         
            bacteria: Results of a prospective, single-center study: Grzegorz Basak, Poland

    17:50-18:00         Inotuzumab ozogamicin (InO) vs. Standard of care (SC) for relapsed/refractory (R/R) acute lymphoblastic leukemia
                         
            (ALL) in the Phase 3 INOVATE Trial: Outcomes in patients who received post-study hematopoietic stem cell
                         
            transplantation (HSCT): David Marks, USA

    ​

    18:00-18:30 - Auditorium

    GA: General Assembly

    Chairs:                 Mohamad Mohty, France & Rafael Duarte, Spain

                                 Outgoing Award recognitions presented by Mohamad Mohty

                                 -Rafael Duarte, Outgoing Working Party Chair

                                 -Andrew Gennery, Outgoing Working Party Chair

                                 -Aleksandra Babic, Outgoing Nurses Group President

    ​

    Wednesday, March 29th

    09:00-10:30 - Les Goudes 1

    S6. EBMT global collaborations: East and West raising the bar together

    Chairs:                  Mohamad Mohty, France; Arnon Nagler, Israel & Christian Chabannon, France
    09:00-09:15         The Australian perspective: David Gottlieb, Australia

    09:15-09:30         The Chinese perspective: Xiao-jun Huang, China

    09:30-09:45         The Indian perspective: Lalit Kumar, India

    09:45-10:00         The Japanese perspective: Life after transplantation: Shinichiro Okamoto, Japan

    10:00-10:15         The Latin American perspective: Raúl Gabus, Uruguay

    10:15-10:30         Round table discussion: Speakers and chairs

     

    11:00-12:30 - Endoume 1

    S7: The best clinical trials of the year

    Chairs:                  Mohamad Mohty, France & Christian Chabannon, France

    11:00-11:15          It is moving fast: Christian Chabannon, France

    11:15-11:30          First in class and revolutionary: Mohamad Mohty, France

    11:30-11:45          Let's reset the system: Riccardo Saccardí, Italy

    11:45-12:00          Two novel options: Arnon Nagler, Israel

    12:00-12:15          Please keep an eye on the checkpoints: Ali Bazarbachi, Lebanon